ANUH PHARMA LTD. - 506260 - Closure of Trading Window
Closure of Trading Window for the Quarter Ended 30th September, 2023.29-09-2023
29-09-2023
ANUH PHARMA LTD. - 506260 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate.13-09-2023
ANUH PHARMA LTD. - 506260 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Scrutinizer Report.22-08-2023
ANUH PHARMA LTD. - 506260 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting Results Under Regulation 44 of LODR.22-08-2023
ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the Q1-2024.21-08-2023
ANUH PHARMA LTD. - 506260 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 - Appointment/Reappointment Of Directors
Intimation under Regulation 30 of the SEBI (LODR)- Appointment/Reappointment of Directors.19-08-2023
ANUH PHARMA LTD. - 506260 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 63rd Annual General Meeting of the Shareholders of the Company19-08-2023
ANUH PHARMA LTD. - 506260 - Results-Financial Results For June 30, 2023.
Results-Financial Results for June 30,2023.11-08-2023
ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Outcome Of Board Meeting Dated 11Th August, 2023.
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the "Board") at its Meeting held today i.e. Friday, 11th August, 2023, inter-alia considered and approved the following agenda Items: 1. The Un-Audited Financial Results along with Limited Review Report thereon for the quarter ended 30th June, 2023.11-08-2023
ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 LODR
Disclosure of Events/Information - Approval from EDQM for CEP of Gliclazide API which is an Anti-Diabetic Drug.11-08-2023